Comparison
11q Partial Monosomy Syndrome C0795841 vs 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
Clinical comparison between 11q Partial Monosomy Syndrome and 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial for differential diagnosis and treatment planning.
11q Partial Monosomy Syndrome C0795841
A chromosomal disorder from missing genetic material on chromosome 11. It typically causes developmental delays, intellectual disability, and facial differences. Care focuses on symptom management and developmental interventions.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
A partial form of enzyme deficiency affecting hormone production. Symptoms vary but may include hormonal imbalances and elevated blood pressure. Treatment usually involves hormone replacement and regular medical follow-up.
6 comparison axes
Onset
11q Partial Monosomy Syndrome C0795841
0-0
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
Variable
Onset patterns differ
Severity
11q Partial Monosomy Syndrome C0795841
severe
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
severe
Different severity levels
Chronic
11q Partial Monosomy Syndrome C0795841
Chronic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
Chronic
Differing course
Communicable
11q Partial Monosomy Syndrome C0795841
No
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
No
Different transmission
Body System
11q Partial Monosomy Syndrome C0795841
congenital
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
endocrine
Same/different system
Category
11q Partial Monosomy Syndrome C0795841
genetic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
endocrine
Different category
Bottom line
11q-partial-monosomy-syndrome-C0795841 and 17-alpha-hydroxylase-17-20-lyase-deficiency-combined-partial-C4017190 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 11q Partial Monosomy Syndrome C0795841 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190 | Discriminating power |
|---|---|---|---|
| Developmental pattern | Developmental delay and intellectual disability are typical from early life. | Primary developmental disability is not established; hormone effects may vary. | High |
| Blood pressure | Hypertension is not a defining feature in the supplied description. | Elevated blood pressure may occur with hormonal imbalance. | Moderate |
| Facial appearance | Facial differences are commonly described. | Characteristic facial differences are not established from the source. | Moderate |
When to favor each condition
Choose 11q Partial Monosomy Syndrome C0795841 when
Congenital developmental concerns
Early developmental delay with facial differences supports chromosomal evaluation.
High
Suspected missing chromosome 11 material
A genetic test suggesting 11q deletion points toward this diagnosis.
High
No dominant endocrine presentation
Absence of hormone-driven findings makes the enzyme disorder less likely, but does not exclude it.
Low
Choose 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190 when
Hormonal imbalance with hypertension
Variable endocrine features and elevated blood pressure fit the supplied description.
Moderate
Abnormal steroid pathway testing
Clinician-confirmed enzyme-pattern results support the endocrine diagnosis.
High
Later or variable recognition
Onset may be variable rather than clearly present at birth.
Moderate
How key tests differ
| Test | 11q Partial Monosomy Syndrome C0795841 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May show missing material involving 11q. | Not expected to establish this enzyme deficiency. | A chromosomal result supports the left condition but needs specialist review. |
| Steroid hormone panel | No characteristic pattern is established here. | May show clinician-interpreted hormone imbalance; exact cutoffs are not supplied. | An abnormal result is not itself a diagnosis. |
| Blood pressure assessment | No specific abnormality is established by the source. | Elevation may be present but is not definitive alone. | Use alongside endocrine evaluation, not as a standalone test. |
Prognosis comparison
11q Partial Monosomy Syndrome C0795841
- Outcome
- Often a lifelong congenital condition with variable developmental needs; exact outcomes are not established.
- Factors
- Extent of missing material, associated anomalies, and access to developmental support.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
- Outcome
- Chronic endocrine condition with variable severity; prognosis depends on hormone control and follow-up.
- Factors
- Degree of enzyme deficiency, blood pressure, treatment response, and monitoring.
Time frame: Both are described as chronic; recognition may be congenital on the left and variable on the right.
Individual findings matter more than the category labels, and no mortality estimate is supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Delays and intellectual disability may require ongoing support. Not established as a core complication. Severity and functional impact vary and need individual assessment. |
| Hypertension-related effects | Not described as characteristic. Elevated blood pressure may contribute to health risk. Monitoring and treatment decisions belong to the clinician. |
| Hormone-related complications | Not established from the supplied data. Partial deficiency may cause variable hormonal effects. Specific manifestations and doses should not be inferred here. |
Patient education highlights
- HighDifferent causes
One condition is chromosomal; the other is a partial hormone-enzyme deficiency. They are not interchangeable diagnoses.
- HighSpecialist follow-up
Genetic or endocrine specialists should interpret tests and coordinate developmental or hormone care.
- MediumWarning symptoms
Report new developmental concerns, blood-pressure symptoms, or signs of hormone imbalance promptly.